NCT00088075View on ClinicalTrials.gov

Investigate Risperidone for the Treatment of Schizophrenia in Adolescents

PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

December 31, 2005

Conditions

Schizophrenia

Interventions

DRUG

Risperidone

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00088075 - Investigate Risperidone for the Treatment of Schizophrenia in Adolescents | Biotech Hunter | Biotech Hunter